article · Frontiers in Artificial Intelligence
Early detection of Alzheimer's disease (AD) is vital for effective treatment, as interventions are most successful in the disease's early stages. Combining Magnetic Resonance Imaging (MRI) with artificial intelligence (AI) offers significant potential for enhancing AD diagnosis. However, traditional AI models often lack transparency in their decision-making processes. Explainable Artificial Intelligence (XAI) is an evolving field that aims to make AI decisions understandable to humans, providing transparency and insight into AI systems. This research introduces the Squeeze-and-Excitation Convolutional Neural Network with Random Forest (SECNN-RF) framework for early AD detection using MRI scans. The SECNN-RF integrates Squeeze-and-Excitation (SE) blocks into a Convolutional Neural Network (CNN) to focus on crucial features and uses Dropout layers to prevent overfitting. It then employs a Random Forest classifier to accurately categorize the extracted features. The SECNN-RF demonstrates high accuracy (99.89%) and offers an explainable analysis, enhancing the model's interpretability. Further exploration of the SECNN framework involved substituting the Random Forest classifier with other machine learning algorithms like Decision Tree, XGBoost, Support Vector Machine, and Gradient Boosting. While all these classifiers improved model performance, Random Forest achieved the highest accuracy, followed closely by XGBoost, Gradient Boosting, Support Vector Machine, and Decision Tree which achieved lower accuracy.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3389/frai.2024.1456069
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.